BioAssets

Biopharma Deals of the Week
InVivo
Fri, 10/30/09 - 09:24 am
Sanofi
Micromet
Cephalon
BioAssets
GSK
Supergen
Astellas
Medivation
Cephalon close to buying BioAssets, developer of sciatica treatment
Bizjournals.com
Mon, 10/26/09 - 11:33 am
sciatica
Cephalon
M&A
BioAssets